SIGA Technologies Inc. Common Stock (SIGA)
Stock · NASDAQ · Health Care
$3.17as of 10/16/2026
Price chart
Active signals
SIGA Signal Track Record
How signals performed across all stocks →What SIGA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakout | 27 | -2.6% | 41% | September 25, 2026 |
| Volume Spike | 28 | -2.1% | 43% | September 1, 2026 |
| Bollinger Band Breakdown | 21 | -0.4% | 43% | July 23, 2026 |
| 200-Day Moving Average TouchActive now | 7 | -6.3% | 43% | May 19, 2025 |
| Any 20-session window (baseline) | -0.8% | 47% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SIGA
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 49
- Website
- www.siga.com/
Fundamentals
- 1-day range
- $3.15$3.28
- Market cap
- $223.78M
- P/E (trailing)
- —
- P/E (forward)
- 2.93
- EPS (trailing)
- $-0.04
- Dividend yield
- —
- Beta
- 1.04
- Avg. volume
- 724.2K
- Ex-dividend date
- April 7, 2026
- Dividend pay date
- April 23, 2026
How SIGA Technologies Inc. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Mar 11, 2025 · via SEC EDGAR / Finnhub
SIGA Technologies Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SIGASIGA Technologies Inc. Common Stock$3.17▼ 0.63%Market cap $223.78MP/E —$2.83$8.55
- ANTXAN2 Therapeutics Inc. Common Stock$3.38▼ 6.11%Market cap $218.98MP/E —$1$7.19
- ACIUAC Immune SA Common Stock$2.39▼ 2.45%Market cap $236.11MP/E —$2.1$4
- KROSKeros Therapeutics Inc. Common Stock$10.66▼ 3.96%Market cap $211.16MP/E —$9.69$22.55
- PYXSPyxis Oncology Inc. Common Stock$1.68▼ 6.67%Market cap $237.58MP/E —$1.03$5.55
- MSLESatellos Bioscience Inc. Common Stock$6.46▼ 5.56%Market cap $209.77MP/E —$7.56$18.98
- GLSIGreenwich LifeSciences Inc. Common Stock$14.55▼ 5.03%Market cap $209.02MP/E —$7.78$34.1
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SIGA SIGA Technologies Inc. Common Stock | $223.78M | — | $3.17 | ▼ 0.63% | $2.83$8.55 |
| ANTX AN2 Therapeutics Inc. Common Stock | $218.98M | — | $3.38 | ▼ 6.11% | $1$7.19 |
| ACIU AC Immune SA Common Stock | $236.11M | — | $2.39 | ▼ 2.45% | $2.1$4 |
| KROS Keros Therapeutics Inc. Common Stock | $211.16M | — | $10.66 | ▼ 3.96% | $9.69$22.55 |
| PYXS Pyxis Oncology Inc. Common Stock | $237.58M | — | $1.68 | ▼ 6.67% | $1.03$5.55 |
| MSLE Satellos Bioscience Inc. Common Stock | $209.77M | — | $6.46 | ▼ 5.56% | $7.56$18.98 |
| GLSI Greenwich LifeSciences Inc. Common Stock | $209.02M | — | $14.55 | ▼ 5.03% | $7.78$34.1 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Joseph W. Marshall III · June 9, 2026 · Grant34.2K
- Joseph W. Marshall III · June 9, 2026 · Option Exercise24.1K
- Harold Eugene Ford Jr. · June 9, 2026 · Grant34.2K
- Harold Eugene Ford Jr. · June 9, 2026 · Option Exercise24.1K
- Phillips Holly L. · June 9, 2026 · Disposition7.2K @ $4.39
- Nemirovsky Julian · June 9, 2026 · Grant34.2K
- Nemirovsky Julian · June 9, 2026 · Option Exercise24.1K
- Nemirovsky Julian · June 9, 2026 · Disposition7.2K @ $4.39
- DURNAN JAYMIE A · June 9, 2026 · Grant34.2K
- DURNAN JAYMIE A · June 9, 2026 · Option Exercise24.1K
- DURNAN JAYMIE A · June 9, 2026 · Disposition7.2K @ $4.39
- Gary J. Nabel · June 9, 2026 · Grant34.2K
- Gary J. Nabel · June 9, 2026 · Option Exercise24.1K
- Gary J. Nabel · June 9, 2026 · Disposition7.2K @ $4.39
- Joseph W. Marshall III · June 9, 2026 · Disposition7.2K @ $4.39
Institutional Ownership
March 31, 2026
- Total shares held
- 33.41M
- Total value held
- $172.36M
- Institutional holders
- 178
- Unknown3.49M
- Unknown2.70M
- Unknown2.43M
- Unknown1.71M
- Unknown1.53M
- Unknown1.32M
- Unknown1.32M
- Unknown1.22M
- Unknown1.01M
- Unknown890.5K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
SIGA Technologies Releases Q2 2026 Earnings Call Transcript
SIGA Technologies has released the full transcript of its Q2 2026 earnings call. The transcript provides details on the company's recent performance and outlook. Investors can review the call to understand the company's guidance and operational highlights. The release is a routine update but offers insight into the company's current status.
SIGA Technologies Releases Q2 2026 Earnings Call Transcript. SIGA Technologies has released the full transcript of its Q2 2026 earnings call. The transcript provides details on the company's recent performance and outlook. Investors can review the call to understand the company's guidance and operational highlights. The release is a routine update but offers insight into the company's current status.